Paraza Pharma

Paraza Pharma operates as a contract research organization (CRO) specializing in integrated drug discovery services, offering a seamless suite of capabilities from medicinal chemistry and computer-aided drug design to in vitro/in vivo pharmacology and DMPK. The company positions itself as a strategic R&D partner focused on innovation, cost-effectiveness, and timely delivery of drug candidates for its clients. Its business model is service-based, generating revenue through collaborative partnerships and fee-for-service work, with a leadership team composed of seasoned industry scientists and executives.

Integrated drug discovery services platform combining Chemical Sciences (Medicinal Chemistry, CADD), Biological Sciences (Biochemistry, Cellular & In Vivo Pharmacology), and DMPK/Bioanalytical capabilities for seamless small molecule and drug delivery R&D.

Paraza competes in the integrated drug discovery services segment against large, global CROs (e.g., Charles River's Discovery Services, Evotec, WuXi AppTec) and smaller boutique firms. Its differentiation is based on a seamless, collaborative partnership model, scientific expertise in small molecules, and its strategic location serving the North American market from a major Canadian biotech hub.